ScoreWhy is Gufic BioSciences Ltd ?
1
The company has declared Negative results for the last 5 consecutive quarters
- INTEREST(9M) At Rs 27.17 cr has Grown at 46.94%
- ROCE(HY) Lowest at 10.87%
- PAT(Q) At Rs 12.42 cr has Fallen at -12.7% (vs previous 4Q average)
2
Stock is technically in a Mildly Bearish range
- The stocks MACD and KST technical factors are also Bearish
3
With ROCE of 11.3, it has a Expensive valuation with a 3.5 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -14.31%, its profits have fallen by -38.4%
4
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 0.10% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -14.31% returns
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Gufic BioScience should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Gufic BioScience for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Gufic BioScience
10.22%
-0.45
31.75%
Sensex
-11.8%
-0.49
12.94%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.79%
EBIT Growth (5y)
4.37%
EBIT to Interest (avg)
5.21
Debt to EBITDA (avg)
2.14
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
1.33
Tax Ratio
26.04%
Dividend Payout Ratio
1.43%
Pledged Shares
0
Institutional Holding
4.14%
ROCE (avg)
20.50%
ROE (avg)
10.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
55
Industry P/E
36
Price to Book Value
6.09
EV to EBIT
32.69
EV to EBITDA
26.57
EV to Capital Employed
4.40
EV to Sales
4.46
PEG Ratio
2.72
Dividend Yield
0.02%
ROCE (Latest)
12.13%
ROE (Latest)
9.66%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend14What is working for the Company
DEBTORS TURNOVER RATIO(HY)
Highest at 3.17 times
OPERATING PROFIT TO INTEREST(Q)
Highest at 5.00 times
NET SALES(Q)
Highest at Rs 260.82 cr
PAT(Q)
Highest at Rs 22.31 cr.
EPS(Q)
Highest at Rs 2.22
-1What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Gufic BioScience
Operating Profit to Interest - Quarterly
Highest at 5.00 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Debtors Turnover Ratio- Half Yearly
Highest at 3.17 times and Grown
each half year in the last five half yearly periodsMOJO Watch
Company has been able to settle its Debtors faster
Debtors Turnover Ratio
Net Sales - Quarterly
Highest at Rs 260.82 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 22.31 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.22
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
